Development of Growth Factor Antagonists

Witt, Daniel P.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Eye Institute (NEI)
• Type: Small Business Innovation Research Grants (SBIR) - Phase I (R43)
• Project #: 7R43EY011333-02
• Application #: 2020035
• Study Section: Special Emphasis Panel (ZRG1-VISA (02))
• Project Start: 1996-03-16
• Project End: 1997-02-06
• Budget Start: 1996-03-16
• Budget End: 1997-02-06
• Support Year: 2
• Fiscal Year: 1996

Institution

• Name: Repligen Corporation
• City: Waltham
• State: MA
• Country: United States
• Zip Code: 02453